Phenacetin and renal pelvic carcinoma.
D000367:Age Factors; D000983:Antipyrine / Q000009:adverse effects; D002110:Caffeine / Q000009:adverse effects; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000139:chemically induced; D007680:Kidney Neoplasms / Q000139:chemically induced* / Q000175:diagnosis / Q000453:epidemiology; D007682:Kidney Pelvis / Q000187:drug effects*; D008297:Male; D010212:Papilloma / Q000453:epidemiology; D010615:Phenacetin / Q000009:adverse effects* / Q000378:metabolism / Q000494:pharmacology / Q000652:urine; D012459:Salicylates / Q000009:adverse effects; D012737:Sex Factors; D019966:Substance-Related Disorders; D013548:Sweden; D013997:Time Factors
D012459:Salicylates; D002110:Caffeine; D010615:Phenacetin; D000983:Antipyrine